Posted by Michael Wonder on 23 Mar 2021
Indian cancer drug manufacturer to pay $50 million for concealing and destroying records in advance of FDA inspection
23 March 2021 - Indian drug manufacturer Fresenius Kabi Oncology was sentenced to pay $50 million in fines and forfeiture after pleading guilty to concealing and destroying records prior to a 2013 U.S. FDA plant inspection.
In a criminal information previously filed in federal court in the District of Nevada, the United States charged Fresenius Kabi Oncology with violating the Federal Food, Drug and Cosmetic Act by failing to provide certain records to FDA investigators.
